Capital M

Briefing with Maryland Senators and Delegates

June 25, 2020 Maryland Tech Council Season 2 Episode 11
Capital M
Briefing with Maryland Senators and Delegates
Chapters
Capital M
Briefing with Maryland Senators and Delegates
Jun 25, 2020 Season 2 Episode 11
Maryland Tech Council

CapitalM ZoomCast Live - COVID Series: Briefing with Maryland Senators and Delegates

In this episode, Maryland Senators and Delegates joined MTC CEO, Marty Rosendale for a robust discussion on how we can translate COVID-19 work into legislation for the 2021 legislative session, other potential COVID-19 biotech or cybersecurity legislation under consideration, and additional actions that the Legislature can take to assist your business and the state.

Thank you to our guests:

  • Senate Finance Committee Vice Chair, Brian Feldman
  • Senate Majority Leader, Nancy King
  • Joint Committee on Cybersecurity, Information Technology and Biotechnology Co-Chair, Senator Katie Fry Hester
  • House Majority Leader and Ways and Means Committee, Revenue Subcommittee Chair, Eric Luedtke
  • Senator Steve Hershey, Senate Finance Committee
  • Delegate Lily Qi, Member of the House Economic Matters Committee
  • Delegate Nick Charles, Member of the House Health and Government Committee
  • Richard Tabuteau, Attorney, Schwartz, Metz & Wise

This episode is sponsored by Amgen. Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology. For more information, visit www.amgen.com or follow on www.twitter.com/amgen.

To watch the full interview or to learn more about CapitalM ZoomCast Live - COVID Series, visit us at mdtechcouncil.com.

Show Notes

CapitalM ZoomCast Live - COVID Series: Briefing with Maryland Senators and Delegates

In this episode, Maryland Senators and Delegates joined MTC CEO, Marty Rosendale for a robust discussion on how we can translate COVID-19 work into legislation for the 2021 legislative session, other potential COVID-19 biotech or cybersecurity legislation under consideration, and additional actions that the Legislature can take to assist your business and the state.

Thank you to our guests:

  • Senate Finance Committee Vice Chair, Brian Feldman
  • Senate Majority Leader, Nancy King
  • Joint Committee on Cybersecurity, Information Technology and Biotechnology Co-Chair, Senator Katie Fry Hester
  • House Majority Leader and Ways and Means Committee, Revenue Subcommittee Chair, Eric Luedtke
  • Senator Steve Hershey, Senate Finance Committee
  • Delegate Lily Qi, Member of the House Economic Matters Committee
  • Delegate Nick Charles, Member of the House Health and Government Committee
  • Richard Tabuteau, Attorney, Schwartz, Metz & Wise

This episode is sponsored by Amgen. Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology. For more information, visit www.amgen.com or follow on www.twitter.com/amgen.

To watch the full interview or to learn more about CapitalM ZoomCast Live - COVID Series, visit us at mdtechcouncil.com.